Here's How AMRX Is Tapping GLP-1 Demand Through Manufacturing

Amneal Pharmaceuticals taps GLP-1 growth via a Pfizer-linked manufacturing deal, gaining exposure without clinical risks while scaling injectables and peptides.

Go to News Site